Some cancer patients see remission with Allogene off-the-shelf CAR-T

Some cancer patients see remission with Allogene off-the-shelf CAR-T

STAT Plus: Some blood cancer patients see remission with Allogene’s off-the-shelf CAR-T cells, early data show

By ADAM FEUERSTEIN

WELLCOME COLLECTION

Allogene released the first data on tumor responses to its off-the-shelf CAR-T cell therapy for an aggressive form of B-cell lymphoma.

READ MORE